Search

everythinglearnresearchcommunity

for

Search:↓

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Efalizumab can cause unexpected excessive hair growth.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Janus kinase inhibitors may help treat lichen planopilaris.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

FR-1 reduces skin scarring and promotes healing without harmful effects.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

BAF200 is essential for proper heart and coronary artery formation.

The document's conclusion cannot be provided because the content is not available.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Kdm6b is crucial for skin cell differentiation.

FOXC1 is essential for keeping hair follicle stem cells inactive and maintaining their environment for healthy hair growth.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

RG and RJ gels speed up burn wound healing better than other treatments.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

JAK inhibitors are effective for long-term management of alopecia areata.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Hormonal changes during the reproductive cycle may cause seasonal skin problems in captive female fossas.